N-Acetylcysteine deserves further evaluation in Crohn's disease according to pilot study May 22, 2001
ASCO presentation documents safety of TLK-286 over wide dose range, efficacy in advanced cancer May 21, 2001
High two-year survival rates obtained in stage III melanoma patients immunized with TriGem May 21, 2001
High exposure to ISIS-2302 associated with significant clinical response in Crohn's disease May 21, 2001
Interim phase II results confirm excellent safety and activity of Allovectin-7 in melanoma May 18, 2001
RSS